125 related articles for article (PubMed ID: 6373303)
1. Comparison of hydrochlorothiazide and atenolol as initial treatment in uncomplicated hypertension.
van der Veur E; ten Berge BS; Donker AJ; May JF; Schuurman FH; Wesseling H
Eur J Clin Pharmacol; 1984; 26(2):157-62. PubMed ID: 6373303
[TBL] [Abstract][Full Text] [Related]
2. A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.
van der Veur E; ten Berge BS; Donker AJ; May JF; Schuurman FH; Wesseling H
Eur J Clin Pharmacol; 1985; 28(5):507-11. PubMed ID: 3899671
[TBL] [Abstract][Full Text] [Related]
3. Safety and antihypertensive efficacy of carvedilol and atenolol alone and in combination with hydrochlorothiazide.
Widmann L; van der Does R; Hörrmann M; Machwirth M
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S143-6. PubMed ID: 1974505
[TBL] [Abstract][Full Text] [Related]
4. Effects of hydrochlorothiazide combined with amiloride in atenolol-resistant hypertensive patients.
Corea L; Bentivoglio M; Verdecchia P
Int J Clin Pharmacol Res; 1983; 3(5):367-70. PubMed ID: 6678830
[TBL] [Abstract][Full Text] [Related]
5. Enalapril maleate and atenolol combined with hydrochlorothiazide in moderate to severe essential hypertension.
Pascoe J; Moon R; Gray D; Musgrove J
N Z Med J; 1985 Nov; 98(790):951-3. PubMed ID: 3001605
[TBL] [Abstract][Full Text] [Related]
6. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
Philipp T; Anlauf M; Distler A; Holzgreve H; Michaelis J; Wellek S
BMJ; 1997 Jul; 315(7101):154-9. PubMed ID: 9251545
[TBL] [Abstract][Full Text] [Related]
7. Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring.
Lacourcière Y; Lefebvre J; Provencher P; Poirier L
Br J Clin Pharmacol; 1993 Feb; 35(2):121-7. PubMed ID: 8443029
[TBL] [Abstract][Full Text] [Related]
8. Comparison of atenolol 50 mg and 100 mg as initial treatment in uncomplicated mild to moderate hypertension.
van der Veur E; ten Berge BS; Donker AJ; May JF; Schuurman FH; Wesseling H
Eur J Clin Pharmacol; 1985; 28(3):351-2. PubMed ID: 4007041
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of carvedilol in comparison with atenolol in hypertensive patients pretreated with hydrochlorothiazide.
van der Does R; Widmann L; Uberbacher HJ; Hörrmann M; Machwirth M; Stienen U
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S147-52. PubMed ID: 1974506
[TBL] [Abstract][Full Text] [Related]
10. Enalapril, atenolol, and hydrochlorothiazide in mild to moderate hypertension. A comparative multicentre study in general practice in Norway.
Helgeland A; Strømmen R; Hagelund CH; Tretli S
Lancet; 1986 Apr; 1(8486):872-5. PubMed ID: 2870352
[TBL] [Abstract][Full Text] [Related]
11. Captopril or atenolol in essential hypertension.
Andrén L; Svensson A; Hansson L
Acta Med Scand Suppl; 1983; 677():115-8. PubMed ID: 6367371
[TBL] [Abstract][Full Text] [Related]
12. Atenolol vs. amiloride-hydrochlorothiazide in the treatment of mild to moderate hypertension: a double-blind, crossover, placebo-controlled study.
Lischner M; Lang R; Jutrin I; Ravid M
Drug Intell Clin Pharm; 1987 Jan; 21(1 Pt 1):43-6. PubMed ID: 3545737
[TBL] [Abstract][Full Text] [Related]
13. Captopril compared to atenolol in mild to moderate hypertension in a randomized double-blind controlled trial.
Havinga TK; ten Berge BS; May JF; Schuurman FH; van der Veur E; Wesseling H
Neth J Med; 1991 Feb; 38(1-2):13-7. PubMed ID: 2030804
[TBL] [Abstract][Full Text] [Related]
14. Haemodynamic findings and response rates to beta-blocker--and diuretic monotherapy in mild and moderate hypertension. A one year randomized, double blind study in 100 men.
Otterstad JE; Erikssen J; Froeland G; Soeyland AK; Saltvedt E
Blood Press; 1992 Dec; 1(4):212-8. PubMed ID: 1345218
[TBL] [Abstract][Full Text] [Related]
15. Pressure and humoral changes induced by atenolol and hydrochlorothiazide + amiloride, alone and in free combination. A comparative between-patient study.
Salvadeo A; Villa G; Segagni S; Piazza V; Galli F
Int J Clin Pharmacol Res; 1983; 3(5):371-7. PubMed ID: 6678831
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of captopril and atenolol in essential hypertension.
Andrén L; Karlberg BE; Svensson A; Ohman P; Nilsson OR; Hansson L
Acta Med Scand; 1985; 217(2):155-60. PubMed ID: 3887847
[TBL] [Abstract][Full Text] [Related]
17. A double blind comparison of perindopril and atenolol in essential hypertension.
Thurston H; Mimran A; Zanchetti A; Creytens G; Rorive G; Brown CL; Santoni JP
J Hum Hypertens; 1990 Oct; 4(5):547-52. PubMed ID: 2283644
[TBL] [Abstract][Full Text] [Related]
18. The long-term antihypertensive effects of prazosin and atenolol.
Itskovitz HD; Krug K; Khoury S; Mollura JL
Am J Med; 1989 Jan; 86(1B):82-6. PubMed ID: 2913776
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
[TBL] [Abstract][Full Text] [Related]
20. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW;
JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
